4.7 Article

A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community-based sample of 70-year-olds

Anna Dittrich et al.

Summary: Neurofilament light protein (NfL) in cerebrospinal fluid (CSF) and plasma (P) have been suggested as interchangeable markers of neurodegeneration. This study found that CSF-NfL and P-NfL have distinct associations with biomarker evidence of Alzheimer's disease (AD) pathology and neurodegeneration, with P-NfL being associated with AD-related markers and CSF-NfL being associated with measures of synaptic and neurodegeneration.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2022)

Article Clinical Neurology

A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer's disease

Melissa M. Budelier et al.

Summary: Budelier et al. have conducted a comprehensive evaluation of neurofilament light chain in CSF and brain tissue using mass spectrometry mapping. They have identified differential isoforms and a new C-terminal fragment of neurofilament light through a novel immunoprecipitation-mass spectrometry assay. The study reveals the expression and characteristics of neurofilament light chain in both CSF and brain tissue, providing insights into its potential utility as a biomarker.

BRAIN COMMUNICATIONS (2022)

Article Clinical Neurology

Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community-based sample of 70-year-olds

Anna Dittrich et al.

Summary: The study found that plasma NfL is associated with markers of Alzheimer's disease pathology and neurodegeneration, while CSF-NfL is linked to markers of synaptic and neurodegeneration.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2022)

Review Clinical Neurology

The Potential of Neurofilament Light as a Biomarker in Alzheimer's Disease

Yong-lan Xiong et al.

Summary: Elevated levels of NFL play an important role in predicting the clinical progression and prognosis of Alzheimer's disease, and are also related to AD core biomarkers, neuroimaging, and cognitive performance.

EUROPEAN NEUROLOGY (2021)

Article Clinical Neurology

Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications

Dario Saracino et al.

Summary: The study found that plasma neurofilament light chain levels increased with age in controls, and were higher in patients with gene-specific trajectories such as C9orf72 and GRN cohorts; repeating pNfL measurements and considering ARC as a prognostic marker of disease progression are important for predicting disease progression in genetic FTD/ALS.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Review Neurosciences

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Federico Verde et al.

Summary: ALS and FTD are currently incurable neurodegenerative diseases lacking specific neurochemical biomarkers, but NFL has shown considerable progress as a biomarker in both diseases, distinguishing them from mimic conditions and providing prognostic information.

FRONTIERS IN NEUROSCIENCE (2021)

Review Neurosciences

Neurofilaments: The C-Reactive Protein of Neurology

Kate L. Lambertsen et al.

BRAIN SCIENCES (2020)

Article Clinical Neurology

First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays

Sebastien Boulo et al.

ALZHEIMERS & DEMENTIA (2020)

Article Clinical Neurology

Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration

Alberto Benussi et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Review Clinical Neurology

Neurofilament light chain as a biomarker in neurological disorders

Lorenzo Gaetani et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Review Clinical Neurology

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis

Kristin N. Varhaug et al.

FRONTIERS IN NEUROLOGY (2019)

Review Medicine, General & Internal

Biomarkers for Alzheimer's disease: current status and prospects for the future

K. Blennow et al.

JOURNAL OF INTERNAL MEDICINE (2018)

Review Clinical Neurology

Neurofilaments as biomarkers in neurological disorders

Michael Khalil et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Cell Biology

Neurofilaments and Neurofilament Proteins in Health and Disease

Aidong Yuan et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)

Article Clinical Neurology

Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis

Giulio Disanto et al.

ANNALS OF NEUROLOGY (2017)

Article Cell Biology

Intermediate Filaments: Structure and Assembly

Harald Herrmann et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)

Article Clinical Neurology

A practical guide to immunoassay method validation

Ulf Andreasson et al.

FRONTIERS IN NEUROLOGY (2015)

Article Biochemistry & Molecular Biology

Characterizing affinity epitopes between prion protein and β-amyloid using an epitope mapping immunoassay

Mino Kang et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2013)

Letter Clinical Neurology

The Neurofilament Light Chain is Not Stable in Vitro

Marleen J. A. Koel-Simmelink et al.

ANNALS OF NEUROLOGY (2011)

Article Biochemical Research Methods

Monoclonal antibodies selective for low molecular weight neurofilaments

N Norgren et al.

HYBRIDOMA AND HYBRIDOMICS (2002)